Gilead Sciences Inc has said it will give India at least 450,000 vials of its antiviral drug remdesivir and help boost production, as the world's second-most populous country reels from surging coronavirus cases.
Remdesivir is approved in India for restricted emergency use to treat severe Covid-19 cases, but hospitals are facing supply shortages due to indiscriminate use and the drug is being sold at over 10 times its listed price in the black market, according to a Reuters report.
The shortage has raised concerns about hoarding as people queue up outside clinics and hospitals to buy the drug and millions take to social media to secure supplies.
